Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
1. Brenner A, Youssef M, Kumthekar P, et al. Rhenium (¹⁸⁶Re) obisbemeda (rhenium nanoliposome, ¹⁸⁶RNL) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback